Contemporary clinical trialsOct 24, 2025

Study plan for comparing two intermittent fasting methods in people with type 2 diabetes

Regenerative Health Weekly Brief ↗PubMed ↗DOI ↗

Updated Jan 7, 2026

Abstract

Fifty-six adults with type 2 diabetes and overweight/obesity are being randomized to compare intermittent energy restriction and time-restricted eating.

Intermittent fasting approaches may improve glycemic control and facilitate diabetes remission in type 2 diabetes.
The study will assess the feasibility and acceptability of intermittent energy restriction and time-restricted eating.
Primary outcomes include recruitment, retention, adherence, and metabolic changes such as HbA1c and insulin sensitivity.
Participants will receive comprehensive diabetes education and support for six months, followed by a six-month low-contact follow-up.
Results may inform strategies to personalize nutrition therapy for individuals with type 2 diabetes.

Simplified

BACKGROUND: Type 2 diabetes (T2D) is a progressive disease driven by insulin resistance and β-cell dysfunction, often exacerbated by excess body weight. Intermittent fasting (IF) approaches, including intermittent energy restriction (IER) and time-restricted eating (TRE), have shown promise for improving glycemic control and facilitating diabetes remission. However, the feasibility and effectiveness of these IF approaches in individuals with T2D remain underexplored.

OBJECTIVE: This study aims to compare the feasibility, acceptability, and metabolic effects of IER and TRE in a randomized parallel trial in adults with T2D.

METHODS: Adults with T2D (N = 56) and overweight/obesity will be randomized to one of two interventions: IER (550-800 kcal/day on 2-3 days/week) or TRE (caloric intake within an 8-h daily window). Both groups will receive a comprehensive, remotely delivered diabetes education and behavioral support program over 6 months, followed by a 6-month low-contact follow-up during which participants continued the intervention on their own. Primary outcomes include feasibility (recruitment, retention, adherence) and acceptability. Secondary outcomes include changes in HbA1c, insulin sensitivity, insulin response to a mixed-meal tolerance test, body composition, and diabetes remission. Continuous glucose monitoring, metabolic and behavioral phenotyping will inform predictors of response.

CONCLUSION: This study is the first parallel trial to compare IER and TRE in patients with T2D and overweight/obesity. Results will provide critical data on the metabolic and behavioral responses to each IF approach, informing future strategies to personalize nutrition therapy in T2D.

Full Text

Full text is available at the source.

View Full Text ↗

Study plan for comparing two intermittent fasting methods in people with type 2 diabetes

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week: